(Q84792928)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20733564%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

editorial

0 references

title

Heterogeneity of blood pressure response to therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20733564%20AND%20SRC:MED&resulttype=core&format=json

https://api.crossref.org/works/10.1038/AJH.2010.139

11 February 2020

Heterogeneity of Blood Pressure Response to Therapy (English)

1 reference

21 June 2024

1 reference

Morris J. Brown

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20733564

21 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20733564

21 June 2024

publication date

1 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20733564%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Hypertension

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20733564%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20733564%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20733564%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

926-928

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20733564%20AND%20SRC:MED&resulttype=core&format=json

A genome-wide search for susceptibility loci to human essential hypertension

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.139

7 January 2021

Optimisation of antihypertensive treatment by crossover rotation of four major classes

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.139

7 January 2021

Genome-wide association study identifies eight loci associated with blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.139

7 January 2021

Choice of biochemical test for diagnosis of pheochromocytoma: validation of plasma metanephrines

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.139

7 January 2021

Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.139

7 January 2021

Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.139

7 January 2021

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.139

7 January 2021

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.139

7 January 2021

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.139

7 January 2021

Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.139

7 January 2021

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.139

7 January 2021

Plasma Renin Activity Predicts Blood Pressure Responses to -Blocker and Thiazide Diuretic as Monotherapy and Add-On Therapy for Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.139

7 January 2021

Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.139

7 January 2021

Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.139

7 January 2021

Pressor responses to antihypertensive drug types

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.139

7 January 2021

The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.139

7 January 2021

Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.139

7 January 2021

Journal of Cardiovascular Pharmacology

4

7

S33

1985

1 reference

https://api.crossref.org/works/10.1038/AJH.2010.139

21 June 2024

Identifiers

DOI

10.1038/AJH.2010.139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20733564%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference